Atrial fibrillation (AF) is the most typical kind of arrhythmia which can be set off by various stressful occasions. About 30 percent of people who have undergone a cardiac operation experience post-operative AF afterward. There are a lot of drugs offered to deal with the condition; nevertheless, they feature a host of negative negative effects such as weight gain, extreme tiredness, breathing difficulty and chest discomfort.
A brand-new study, released in the journal BMC Cardiovascular Disorders, found that oral administration of extra vitamin C after heart surgical treatment could slash the threat of AF by as much as 73 percent in high-risk clients, without including negative effects. Additionally, the Finnish scientists reported that intravenous administration of vitamin C considerably lowered the length of hospital stay.
Individuals with AF experience an unusual heart rhythm characterized by fast and irregular pounding which can increase the chances of suffering an embolism, stroke, heart failure and other heart-related complications.
Throughout AF, the top chambers of the heart, or the atria, beat in a really rapid, irregular and disorderly pattern. The pumping lower chambers of the heart, called ventricles, are also beating irregularly, out of coordination with the two upper chambers. With the fast and chaotic heart rate, patients typically experience heart palpitations, shortness of breath and weak point. AF episodes can come and go, but for some, they don’t disappear and may need emergency treatment.
Dr. Glenn Rothfeld, who was not associated with the research study, stated that there is some circumstantial proof connecting AF flare-ups to oxidative tension and swelling. This proof got researchers all over the world questioning whether a powerful antioxidant like vitamin C could assist prevent AF.
Role of vitamin C in the avoidance of atrial fibrillation after surgical treatment
The research group from the University and Health center of Helsinki, Finland, examined 14 randomized cardiac surgery trials involving 2,006 clients who had undergone cardiac surgical treatment. Another trial that investigated AF recurrence after a successful cardioversion was also consisted of in the evaluation.
The study, led by Harri Hemilä from the University of Helsinki, and Timo Suonsyrjä from the Helsinki University Central Healthcare facility, concluded that oral vitamin C supplements lowered the occurrence of postoperative AF by 73 percent, while intravenous administration only decreased the event by 36 percent. On the contrary, intravenous administration substantially decreased the hospital stay by 16 percent, or 1.5 days, compared to only 7 percent, or 0.4 days, when vitamin C was taken orally.
However, the team kept in mind that the heart protective result seems to be nation particular. When the research information was split by geographic and socio-economic demographics, the results suggested that vitamin C just had a strong protective effect for the less rich nations outside the United States.
“Vitamin C is a safe inexpensive vital nutrient. Offered the constant evidence from the less rich nations, vitamin C might be administered to cardiac surgery clients,” said Drs. Hemilä and Suonsyrjä.
Planning to the future, the team said that more research study needs to be brought out to find optimal protocols for its administration and figure out which patients can benefit from vitamin C treatment. They included that there is no intention for further examination of unselected patients in rich countries. However, the results of vitamin C for clients who have actually a low recorded level of vitamin C in the richer countries, such as the United States, may still be rewarding.